{"ORPHApacket":[{"ORPHApacketID":"251359","date":"2019-12-06 01:11:29","version":"1.3.1 \/ 4.1.7 [2019-11-24] (orientdb version)","copyright":"Orphanet (c) 2019","ORPHA":"251359","Name":[{"lang":"en","label":"Sickle cell-beta-thalassemia disease syndrome"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_251359","DisorderType":[{"Name":[{"lang":"en","label":"Disease"}],"PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_377788"}],"SubClassOfList":[{"Disorder":[{"Name":[{"lang":"en","label":"Sickle cell disease associated with an other hemoglobin anomaly"}],"ORPHA":"251355","PURL":"http:\/\/www.orpha.net\/ORDO\/Orphanet_251355"}]}],"TextSection":[{"Name":[{"lang":"en","label":"Definition"}],"Contents":"A rare, genetic hemoglobinopathy that affects red blood cells both in the production of abnormal hemoglobin, as well as the decreased synthesis of beta globin chains. Clinical manifestations depend on the amount of residual beta globin chains production, and are similar to sickle cell disease, including anemia, vascular occlusion and its complications, acute episodes of pain, acute chest syndrome, pulmonary hypertension, sepsis, ischemic brain injury, splenic sequestration crisis and splenomegaly."}],"AverageAgeOfOnsetList":[{"count":"1","AverageAgeOfOnset":[{"Name":[{"lang":"en","label":"All ages"}]}]}],"TypeOfInheritanceList":[{"count":"1","TypeOfInheritance":[{"Name":[{"lang":"en","label":"Autosomal recessive"}]}]}],"SynonymList":[{"count":"1","Synonym":[{"lang":"en","label":"HbS-beta-thalassemia syndrome"}]}],"DisorderGeneAssociationList":[{"count":"1","DisorderGeneAssociation":[{"Gene":[{"Name":[{"lang":"en","label":"hemoglobin subunit beta"}],"Symbol":"HBB","ExternalReferenceList":[{"count":"2","ExternalReference":[{"Source":"HGNC","Reference":"4827"},{"Source":"OMIM","Reference":"141900"}]}]}],"DisorderGeneAssociationType":[{"OrphaNumber":"317343","Name":[{"lang":"en","label":"Disease-causing germline mutation(s) in"}]}]}]}]}]}